Top Markets
#1 TENDIES TENDIES +42.31%
#2 Cash Cat Cash Cat +24.22%
#3 Asteroid Shiba Asteroid Shiba +16.17%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.93%
#6 Bluwhale Bluwhale +10.55%
#7 MarsCoin MarsCoin +8.17%
#8 Threshold Network Threshold Network +7.55%
#9 Pyth Network Pyth Network +7.25%
#10 Tornado Cash Tornado Cash +6.90%
Coin of the day
TENDIES TENDIES
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Oryzon Genomics S.A. Oryzon Genomics S.A.

Oryzon Genomics S.A.

ORY
Classement en actions #16843
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Prix de l'action
$3.31
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$271.03M
Changement (1 jour)
-0.36%
Changement (1 an)
8.04%
Pays
ES
Échange Oryzon Genomics S.A. (ORY)

Catégorie

Healthcare
Le prix ORY avec la capitalisation boursière de B
Oryzon Genomics S.A. Oryzon Genomics S.A.
ORY
$3.31
Capitalisation boursière de Oryzon Genomics S.A.(ORY)
Capitalisation boursière: $271.03M
En September 2026, Oryzon Genomics S.A. a une capitalisation boursière de $271.03M. Cela fait de Oryzon Genomics S.A. la 16843rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Oryzon Genomics S.A. du 2015 au 2026
ORY par rapport au top 5 des plus populaires stocks
Prix pour ORY L’actif B La capitalisation boursière de B Résultats
Oryzon Genomics S.A. Oryzon Genomics S.A.
$64,174.86 $271.03M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,940,475.84%
Oryzon Genomics S.A. Oryzon Genomics S.A.
$58,305.00 $271.03M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,762,978.10%
Oryzon Genomics S.A. Oryzon Genomics S.A.
$49,010.06 $271.03M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,481,909.34%
Oryzon Genomics S.A. Oryzon Genomics S.A.
$45,380.96 $271.03M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,372,169.56%
Oryzon Genomics S.A. Oryzon Genomics S.A.
$33,361.68 $271.03M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,008,720.02%